This study is in progress, not accepting new patients
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Nicholas Fidelman (ucsf)
Description
Summary
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Nicholas Fidelman (ucsf)
Nicholas Fidelman, MD, is a Professor of Clinical Radiology at the University of California, San Francisco and UCSF Mount Zion. Dr. Fidelman received his medical degree from UCSF in 2002, and completed his residency in Diagnostic Radiology from UCSF in 2007, followed by a fellowship in Interventional Radiology from UCSF in 2008.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine
- ID
- NCT02724540
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 162 people participating
- Last Updated